Annual Total Long Term Liabilities
$28.15 M
+$60.00 K+0.21%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total long term liabilities is $28.15 million, with the most recent change of +$60.00 thousand (+0.21%) on June 30, 2024.
- During the last 3 years, AYTU annual total long term liabilities has risen by +$9.49 million (+50.85%).
- AYTU annual total long term liabilities is now -4.62% below its all-time high of $29.52 million, reached on June 30, 2020.
Performance
AYTU Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$24.75 M
-$3.40 M-12.07%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total long term liabilities is $24.75 million, with the most recent change of -$3.40 million (-12.07%) on September 30, 2024.
- Over the past year, AYTU quarterly long term liabilities has dropped by -$10.51 million (-29.79%).
- AYTU quarterly long term liabilities is now -44.65% below its all-time high of $44.72 million, reached on March 31, 2021.
Performance
AYTU Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AYTU Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.2% | -29.8% |
| 3 y3 years | +50.9% | +35.8% |
| 5 y5 years | +26.5% | -44.6% |
AYTU Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.5% | +50.9% | -29.8% | +71.9% |
| 5 y | 5-year | -4.6% | +50.9% | -44.6% | +71.9% |
| alltime | all time | -4.6% | -100.0% | -44.6% | -100.0% |
Aytu BioPharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.75 M(-12.1%) |
| Jun 2024 | $28.15 M(+0.2%) | $28.15 M(+95.5%) |
| Mar 2024 | - | $14.40 M(-57.9%) |
| Dec 2023 | - | $34.21 M(-3.0%) |
| Sep 2023 | - | $35.26 M(+25.5%) |
| Jun 2023 | $28.09 M(-2.7%) | $28.09 M(+34.5%) |
| Mar 2023 | - | $20.89 M(-26.6%) |
| Dec 2022 | - | $28.47 M(+24.4%) |
| Sep 2022 | - | $22.89 M(-20.7%) |
| Jun 2022 | $28.87 M(+54.7%) | $28.87 M(+5.7%) |
| Mar 2022 | - | $27.32 M(+54.2%) |
| Dec 2021 | - | $17.72 M(-2.8%) |
| Sep 2021 | - | $18.23 M(-2.3%) |
| Jun 2021 | $18.66 M(-36.8%) | $18.66 M(-58.3%) |
| Mar 2021 | - | $44.72 M(+58.4%) |
| Dec 2020 | - | $28.24 M(-1.6%) |
| Sep 2020 | - | $28.70 M(-2.8%) |
| Jun 2020 | $29.52 M(+32.6%) | $29.52 M(-5.5%) |
| Mar 2020 | - | $31.22 M(-24.7%) |
| Dec 2019 | - | $41.44 M(+83.4%) |
| Sep 2019 | - | $22.60 M(+1.5%) |
| Jun 2019 | $22.26 M(+424.9%) | $22.26 M(+25.1%) |
| Mar 2019 | - | $17.80 M(-0.3%) |
| Dec 2018 | - | $17.85 M(+318.2%) |
| Sep 2018 | - | $4.27 M(+0.6%) |
| Jun 2018 | $4.24 M(-42.6%) | $4.24 M(-32.5%) |
| Mar 2018 | - | $6.28 M(-43.0%) |
| Dec 2017 | - | $11.03 M(-3.1%) |
| Sep 2017 | - | $11.38 M(+54.1%) |
| Jun 2017 | $7.39 M(+77.9%) | $7.39 M(+82.8%) |
| Mar 2017 | - | $4.04 M(-1.2%) |
| Dec 2016 | - | $4.09 M(-4.6%) |
| Sep 2016 | - | $4.28 M(+3.1%) |
| Jun 2016 | $4.15 M | $4.15 M(+241.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $1.21 M(-80.9%) |
| Dec 2015 | - | $6.35 M(+2.8%) |
| Sep 2015 | - | $6.17 M(+465.7%) |
| Jun 2015 | $1.09 M(>+9900.0%) | $1.09 M(+144.0%) |
| Mar 2015 | - | $447.30 K(>+9900.0%) |
| Feb 2015 | - | $0.00(0.0%) |
| Nov 2014 | - | $0.00(0.0%) |
| Aug 2014 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2014 | $554.40 K(>+9900.0%) | - |
| May 2014 | - | $0.00(0.0%) |
| Feb 2014 | - | $0.00(0.0%) |
| Nov 2013 | - | $0.00(0.0%) |
| Aug 2013 | $0.00(0.0%) | $0.00(0.0%) |
| May 2013 | - | $0.00(0.0%) |
| Feb 2013 | - | $0.00(0.0%) |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | $0.00(0.0%) | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | - | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) |
| Aug 2009 | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) |
| Feb 2009 | - | $0.00(0.0%) |
| Aug 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2007 | $0.00 | $0.00(0.0%) |
| May 2007 | - | $0.00 |
FAQ
- What is Aytu BioPharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aytu BioPharma?
- What is Aytu BioPharma annual total long term liabilities year-on-year change?
- What is Aytu BioPharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aytu BioPharma?
- What is Aytu BioPharma quarterly long term liabilities year-on-year change?
What is Aytu BioPharma annual total long term liabilities?
The current annual total long term liabilities of AYTU is $28.15 M
What is the all time high annual total long term liabilities for Aytu BioPharma?
Aytu BioPharma all-time high annual total long term liabilities is $29.52 M
What is Aytu BioPharma annual total long term liabilities year-on-year change?
Over the past year, AYTU annual total long term liabilities has changed by +$60.00 K (+0.21%)
What is Aytu BioPharma quarterly total long term liabilities?
The current quarterly long term liabilities of AYTU is $24.75 M
What is the all time high quarterly long term liabilities for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total long term liabilities is $44.72 M
What is Aytu BioPharma quarterly long term liabilities year-on-year change?
Over the past year, AYTU quarterly total long term liabilities has changed by -$10.51 M (-29.79%)